missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed)
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 6420-CL-025/CF
2568.40 DKK valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
Measured in a cell proliferation assay using enriched human B cells in the presence of IL-4. Spriggs, M.K. et al. (1992) J. Exp. Med. 176:1543. The ED50 for this effect is 0.2-1.2 ng/mL in the presence of 20 ng/mL of Recombinant Human IL-4 (Catalog # 204-IL ) and a cross-linking antibody, Mouse Anti-Hemagglutinin/HA Peptide Monoclonal Antibody (Catalog # MAB060 ).Specifications
P29965 | |
Lyophilized from a 0.2 μm filtered solution in PBS and EDTA. | |
M.W. (Observed): 22-26 kDa, reducing condtions; M.W. (theoretical): 21.6 kDa | |
25 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
CD40LG | |
Recombinant | |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Bioactivity | |
959 | |
CD40 Ligand/TNFSF5 | |
Human embryonic kidney cell, HEK293-derived human CD40 Ligand/TNFSF5 protein Hemagglutinin tag YPYDVPDYA GCN4-IZ (Met1-Ile29) GGGSGGGSGGGS Human CD40 Ligand (Met113-Leu261) (N-terminus) Accession # P29965 (C-terminus) | |
<0.01 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
Reconstitute at 100 μg/mL in PBS. | |
CD40 Ligand/TNFSF5 |